Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Year 1	STARTED	Autologous UCB Reinfusion First, Then Placebo	32
Year 1	STARTED	Placebo First, Then Autologous UCB Reinfusion	31
Year 1	COMPLETED	Autologous UCB Reinfusion First, Then Placebo	32
Year 1	COMPLETED	Placebo First, Then Autologous UCB Reinfusion	31
Year 1	NOT COMPLETED	Autologous UCB Reinfusion First, Then Placebo	0
Year 1	NOT COMPLETED	Placebo First, Then Autologous UCB Reinfusion	0
Year 2	STARTED	Autologous UCB Reinfusion First, Then Placebo	32
Year 2	STARTED	Placebo First, Then Autologous UCB Reinfusion	31
Year 2	COMPLETED	Autologous UCB Reinfusion First, Then Placebo	30
Year 2	COMPLETED	Placebo First, Then Autologous UCB Reinfusion	28
Year 2	NOT COMPLETED	Autologous UCB Reinfusion First, Then Placebo	2
Year 2	NOT COMPLETED	Placebo First, Then Autologous UCB Reinfusion	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01147653/flow